Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes: Findings From Two Large Prospective Cohorts — Anna Birukov (2024) | RDL Network
Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes: Findings From Two Large Prospective Cohorts
Article 2024 en
Authors
AB
Anna Birukov
MG
Marta Guasch‐Ferré
SL
Sylvia H. Ley
Abstract
1 min read
OBJECTIVE Breastfeeding duration is inversely associated with risks of cardiovascular disease (CVD) and type 2 diabetes in parous women. However, the association among women at high risk, including women with type 2 diabetes or gestational diabetes mellitus (GDM) is unclear. RESEARCH DESIGN AND METHODS We included 15,146 parous women with type 2 diabetes from the Nurses’ Health Study I and II (NHS, NHS II) and 4,537 women with a history of GDM from NHS II. Participants reported history of breastfeeding via follow-up questionnaires. Incident CVD by 2017 comprised stroke or coronary heart disease (CHD) (myocardial infarction, coronary revascularization). Adjusted hazard ratios (aHRs) and 95% CIs were estimated using Cox models. RESULTS We documented 1,159 incident CVD cases among women with type 2 diabetes in both cohorts during 188,874 person-years of follow-up and 132 incident CVD cases among women with a GDM history during 100,218 person-years of follow-up. Longer lifetime duration of breastfeeding was significantly associated with lower CVD risk among women with type 2 diabetes, with pooled aHR of 0.68 (95% CI 0.54–0.85) for >18 months versus 0 months and 0.94 (0.91–0.98) per 6-month increment in breastfeeding. Similar associations were observed with CHD (pooled aHR 0.93 [0.88–0.97]) but not with stroke (0.96 [0.91–1.02]) per 6-month increment in breastfeeding. Among women with GDM history, >18 months versus 0 months of breastfeeding was associated with an aHR of 0.49 (0.28–0.86) for total CVD. CONCLUSIONS Longer duration of breastfeeding was associated with lower risk of CVD in women with type 2 diabetes or GDM.
Anna Birukov, Marta Guasch‐Ferré, Sylvia H. Ley, Deirdre K. Tobias, Fenglei Wang, Clemens Wittenbecher, Jiaxi Yang, JoAnn E. Manson, Jorge E. Chavarro, Frank B Hu, CUILIN ZHANG
Anna Birukov, Marta Guasch‐Ferré, Sylvia H. Ley, Deirdre K. Tobias, Fenglei Wang, Clemens Wittenbecher, Jiaxi Yang, JoAnn E. Manson, Jorge E. Chavarro, Frank B Hu, CUILIN ZHANG
Sylvia H. Ley, Jorge E. Chavarro, Mengying Li, Wei Bao, Stefanie N. Hinkle, Pandora L. Wander, Janet W. Rich‐Edwards, Sjúrđur F. Olsen, Allan Vaag, Peter Damm, Louise Groth Grunnet, James L. Mills, Frank B Hu, CUILIN ZHANG
Anna Birukov, Marta Guasch‐Ferré, Deirdre K. Tobias, Sylvia H. Ley, Clemens Wittenbecher, Jiaxi Yang, JoAnn E. Manson, Jorge E. Chavarro, Frank B Hu, CUILIN ZHANG
Camille E. Powe, Deirdre K. Tobias, Karin B. Michels, Wendy Y. Chen, A. Heather Eliassen, JoAnn E. Manson, Bernard Rosner, Walter C. Willett, Frank B Hu, CUILIN ZHANG, Janet W. Rich‐Edwards, Kathryn M. Rexrode
Discussion(0)
No comments yet. Be the first to comment.